GL1X · GenesisL1 explorer

MolNFT v1 · #99711 · protein

Crystal structure of K234R inhibitor-resistant variant of shv beta- lactamase in complex with SA2-13

4MBK · Beta-lactamase shv-1: “Crystal structure of K234R inhibitor-resistant variant of shv beta- lactamase in complex with SA2-13”. X-ray diffraction, 2 ligands (MA4, SA2), 2 pockets (best druggability 0.67). MolNFT v1 #99711 on…

PDB
4MBK
Type
protein
Length
265 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase shv-1
EC
3.5.2.6
UniProt
P0AD64
Ligands
MA4, SA2
Pockets
2 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase shv-1 (EC 3.5.2.6)protein26546% helix, 17% strandP0AD64

Ligands and binding sites

  • MA4 · Cyclohexyl-hexyl-beta-D-maltoside · ligand · 2 copies · chains A
  • SA2 · (3R)-4-[(4-carboxybutanoyl)oxy]-N-[(1E)-3-oxoprop-1-en-1-yl]-3-sulfino-D-valine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11980.670.8525MA4
2510.270.7516SA2

Modifications

Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

  • 4MBK · Crystal structure of K234R inhibitor-resistant variant of SHV beta-lactamase in complex… · the same entry in another collection · chain A against A, TM-score 1.00
  • P0AD64 · AlphaFold monomer V2.0 prediction for beta-lactamase shv-1 (P0AD64) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.